CASULA, MANUELA
 Distribuzione geografica
Continente #
EU - Europa 17.871
AS - Asia 10.739
NA - Nord America 8.663
SA - Sud America 2.821
AF - Africa 708
OC - Oceania 560
Continente sconosciuto - Info sul continente non disponibili 58
Totale 41.420
Nazione #
US - Stati Uniti d'America 6.735
CN - Cina 3.984
IT - Italia 2.970
DE - Germania 2.805
ES - Italia 2.291
GB - Regno Unito 2.245
IN - India 1.233
MX - Messico 1.222
FR - Francia 1.101
BR - Brasile 1.017
JP - Giappone 1.007
CO - Colombia 640
CH - Svizzera 609
SE - Svezia 596
TR - Turchia 541
KR - Corea 521
CA - Canada 485
AU - Australia 474
NL - Olanda 465
AT - Austria 460
HK - Hong Kong 457
PT - Portogallo 443
PL - Polonia 431
IE - Irlanda 419
ID - Indonesia 404
SG - Singapore 397
GR - Grecia 394
TW - Taiwan 377
AR - Argentina 370
RU - Federazione Russa 352
VN - Vietnam 352
BE - Belgio 342
DK - Danimarca 341
TH - Thailandia 330
PE - Perù 279
FI - Finlandia 237
EG - Egitto 234
EC - Ecuador 208
RO - Romania 208
CL - Cile 205
MY - Malesia 179
IL - Israele 153
ZA - Sudafrica 143
CZ - Repubblica Ceca 134
NO - Norvegia 134
SA - Arabia Saudita 129
IR - Iran 118
HR - Croazia 112
PH - Filippine 107
SI - Slovenia 104
SK - Slovacchia (Repubblica Slovacca) 93
UA - Ucraina 93
BG - Bulgaria 91
RS - Serbia 86
HU - Ungheria 84
AE - Emirati Arabi Uniti 83
NZ - Nuova Zelanda 83
CR - Costa Rica 63
PK - Pakistan 58
BA - Bosnia-Erzegovina 52
DZ - Algeria 52
LT - Lituania 48
NG - Nigeria 47
VE - Venezuela 45
TN - Tunisia 43
LB - Libano 42
MA - Marocco 38
UY - Uruguay 33
ET - Etiopia 32
EU - Europa 31
GT - Guatemala 28
IQ - Iraq 27
QA - Qatar 27
AP - ???statistics.table.value.countryCode.AP??? 25
JO - Giordania 25
CY - Cipro 24
EE - Estonia 24
KE - Kenya 24
DO - Repubblica Dominicana 23
MO - Macao, regione amministrativa speciale della Cina 23
KZ - Kazakistan 20
HN - Honduras 19
BO - Bolivia 18
BY - Bielorussia 18
PA - Panama 18
CU - Cuba 15
KW - Kuwait 15
LV - Lettonia 15
OM - Oman 15
RE - Reunion 15
MT - Malta 14
BD - Bangladesh 13
CM - Camerun 13
LK - Sri Lanka 12
PR - Porto Rico 12
SV - El Salvador 12
IS - Islanda 11
MK - Macedonia 11
YE - Yemen 11
AL - Albania 10
Totale 41.228
Città #
Southend 817
Beijing 493
Milan 493
Shanghai 395
Madrid 343
Frankfurt am Main 339
Tokyo 316
Redwood City 308
Dublin 299
Barcelona 275
Bormujos 271
Bogotá 267
Guangzhou 238
Vienna 238
Rome 226
Fairfield 222
Paris 210
New York 205
Chandler 202
London 197
Hanover 196
Istanbul 193
Lima 191
Taipei 191
Nanjing 190
Singapore 188
Ashburn 184
Berlin 176
Mumbai 176
Mexico City 173
Bengaluru 170
Bangkok 163
Duncan 163
Athens 162
Seattle 160
Hanoi 149
Wilmington 146
Central 144
Chicago 144
Houston 143
Buenos Aires 139
São Paulo 139
Zurich 128
Melbourne 126
Sydney 124
Helsinki 121
Jakarta 121
Hong Kong 120
Menlo Park 116
Princeton 115
Woodbridge 113
Ho Chi Minh City 112
Stockholm 112
Warsaw 108
Seoul 106
Cambridge 105
Chennai 103
Amsterdam 102
Wuhan 102
Hangzhou 101
Moscow 101
Santiago 101
Ann Arbor 99
Kuala Lumpur 99
Medellín 99
Munich 98
Los Angeles 96
Copenhagen 94
Delhi 92
Brussels 89
Chengdu 89
Hamburg 89
Cairo 88
Hyderabad 87
Atlanta 86
Tianjin 86
Bologna 80
Valencia 80
Toronto 79
Ankara 76
Guayaquil 76
Changsha 75
Quito 75
Guadalajara 74
Lisbon 74
Shenyang 72
Naples 69
Breda 66
Turin 62
Mexico 61
Jinan 60
Rio de Janeiro 59
Montreal 58
Osaka 58
Padova 58
Zagreb 56
Monterrey 55
Düsseldorf 54
Dallas 53
Riyadh 53
Totale 15.145
Nome #
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk 20.947
2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk 8.864
Statin use and risk of new-onset diabetes : A meta-analysis of observational studies 2.875
Statin use and risk of dementia or Alzheimer's disease : a systematic review and meta-analysis of observational studies 2.545
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 733
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 600
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 377
Use of proton pump inhibitors and risk of ischemic events in the general population 343
Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: need for customisation strategies 305
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 274
Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database 269
Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study 224
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting : the PROSISA Study 178
Prevalence of the prescription of potentially interacting drugs 166
Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues : a Retrospective Population-Based Cohort Study 163
Detection of familial hypercholesterolemia in patients from a general practice database 141
Reply to: "Statins probably do not cause cataracts" 134
Multilevel Models to Estimate Carotid Intima-Media Thickness Curves for Individual Cardiovascular Risk Evaluation 114
Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy : the CHECK Study 109
Global epidemiology of dyslipidaemias 97
Cardiovascular events with PCSK9 inhibitors : an updated meta-analysis of randomised controlled trials 95
Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study 93
Epidemiology of cardiovascular risk factors in two population-based studies 92
Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population 86
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub-study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 85
Adherence to lipid-lowering treatment : the patient perspective 81
Statins and the risk of diabetes : evidence from a large population-based cohort study 78
Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) andtriglyceride-rich lipoprotein metabolism: Facts and gaps 78
Reduction of cardio-metabolic risk and body weight through a multiphasic very-low calorie ketogenic diet program in women with overweight/obesity: A study in a real-world setting 78
Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies 77
Corrigendum to “Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database” [Diabetes Res. Clin. Pract. (2015) 108(2) (243–249)] (S0168822715001138)(10.1016/j.diabres.2015.02.013) 76
Lipid Lowering and Incidence of Cataract, a Role for Fibrates 72
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials 71
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 71
Risk Factors Distribution and Cardiovascular Disease Prevalence in a Representative Sample of Italian Population: The CHECK Study 71
C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population 69
Are generic and brand-name statins clinically equivalent? Evidence from a real data-base 69
Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy 69
Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials 68
Tools to investigate and avoid drug-hypersensitivity in drug development 68
Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. The results of the CHECK study 66
Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia 66
HDL in atherosclerotic cardiovascular disease : In search of a role 66
A simple informative intervention in primary care increases statin adherence 60
Nutraceuticals for dyslipidaemia and glucometabolic diseases : what the guidelines tell us (and do not tell, yet) 60
How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort 59
How registers could enhance knowledge and characterization of genetic dyslipidaemias : The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia 58
Global perspective of familial hypercholesterolaemia : a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 57
Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study 54
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG Project 48
High-potency statins increase the risk of acute kidney injury : evidence from a large population-based study 48
Statin use and risk of cataract : a nested case-control study within a healthcare database 45
Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease : The POSTER study 44
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease 44
PCSK9 inhibition in statin-intolerant HeFH patients : what's new? 40
Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy 37
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia : Implications for clinical diagnosis 35
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 34
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study 32
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 31
Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study 29
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies 28
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events 27
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 26
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment 25
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 25
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review 24
Appropriateness of the Prescription and Use of Medicines: An Old Concept but More Relevant than Ever 24
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk 23
Prescrizione dei farmaci per la terapia dell’osteoporosi nella ASL di Bergamo: anni 2006, 2007 e 2008 = Prescription of anti-osteoporosis drugs during 2006-2008 in an Italian local health unit 23
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 21
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 20
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolemia: insights from the Italian LIPIGEN Registry 10
Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials 8
Longevity-associated BPIFB4 gene counteracts the inflammatory signaling. 6
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 6
Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis 1
Totale 42.315
Categoria #
all - tutte 63.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.946 145 73 66 150 118 98 231 153 289 286 181 156
2020/20213.637 183 194 239 257 316 227 307 291 329 357 438 499
2021/20228.938 659 686 755 760 745 620 704 1.057 961 662 668 661
2022/202310.091 594 533 605 644 690 813 970 1.128 1.094 850 1.115 1.055
2023/202415.063 1.184 1.151 1.304 1.453 1.557 1.015 1.168 1.209 1.228 1.202 1.393 1.199
2024/2025823 823 0 0 0 0 0 0 0 0 0 0 0
Totale 42.315